Navigation Links
Microlife WatchBP Invites Medical Professionals for a 'New way through together' at ESH Meeting
Date:6/11/2009

WIDNAU, Switzerland, June 12 /PRNewswire-Asia/ -- According to National Stroke Association, high blood pressure is the one of the top two stroke risk factors. To measure true blood pressure is crucial and indispensable for hypertension treatment and management. From perspectives of primary care doctors and physicians, how to obtain the best estimation of a patient's "true" blood pressure in an accurate way is very important for their daily diagnoses and treatment outcomes. Blood pressure measurement devices for office, home, and ambulatory use indubitably play an important role in such diagnoses and treatment.

Microlife, known as one of the global market leaders in the development and manufacturing of medical diagnostic devices for home monitoring and clinical use, initiates "A New Way Through Together" to have hypertension under control by 2015. With such a concept of "A New Way Through Together", Microlife opened intensive dialogues with worldwide medical societies, physicians, doctors, specialists, patients, and pharmas, in order to empower each individual to be able to manage his own health. Microlife WatchBP(R) solution, based on extensive long-term clinical research and many dialogues with medical societies, physicians and patients, is ultimate solution for blood pressure measurement for both doctors and patients. The WatchBP(R) family of blood pressure monitors is with implemented schedules that support measuring according to European Society of Hypertension (ESH) guidelines.(1, 2) In addition to aforementioned hardware, the easy-to-use software, called "WatchBP(R) analyzer", clearly presents data for easy diagnosis by doctors. Today many doctors have experienced such a convenience by using WatchBP(R).

    Major advantages of WatchBP(R) family in professional use are as follows:

    -- WatchBP(R) Office: simultaneous double-arm measurements, following
       WHO/ESH/AHA measurement protocol, and
'/>"/>
SOURCE Microlife
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Daisy Brand(R) Cottage Cheese Invites Americans to Freshen Up Your Fridge
2. HealthCore Invites Community-based Practitioners to Participate in Real-world Research Network
3. Toms of Maine Invites Public Participation in 50 States for Good Program
4. OWATER Invites Inspirational Athletes to Share Their Stories on Sports Drink Labels
5. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
6. DURECT Corporation Invites You to Join its First Quarter 2009 Earnings Conference Call
7. Six Flags Friends Invites Guests to Help Cure Kids Cancer by Taking A Walk In The Park
8. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Second Quarter Earnings Webcast
9. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
10. Leading Autism Care Provider Invites MPs to Meet Residents and Staff for World Autism Awareness Day
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Cowen Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Video: Grin Big With an Award-Winning Smile 2Health News:Video: Grin Big With an Award-Winning Smile 3Health News:Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years 2Health News:Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years 3Health News:Pharmos Restructures Operations in Israel 2Health News:Pharmos Restructures Operations in Israel 3Health News:Ranbaxy Receives Tentative Approval For Valsartan Tablets 2Health News:TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock 2Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 2Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 3Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 4Health News:Merge Healthcare Provides Update on the Restatement of Its Financial Statements 5
Breaking Medicine Technology:Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4New Executive Leadership and CEO Announced for BiPar Sciences 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 1Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 2Women 26apos 3Bs Pelvic Organ Prolapse and Incontinence Guide Informs Outlines Treatments 57906 3Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 1Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 2Link High Technologies to Offer Allscripts MyWay Affordable Electronic Health Records to NJ Physicians 57903 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in Second Line Metastatic Colorectal Cancer 5028 8